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Abstract
Background: There is sparse literature providing evidence for postoperative pain treatment in day surgery and for differences
between morphine and oxycodone.
Objectives: The objectives of this study were to examine the need for opioids and the effects of morphine versus oxycodone for pain
relief and side effects at home after day surgery.
Methods: This study was a prospective observational study with a quasi-randomized approach. Data consisted of self-reported
three-day registration of use and the effects of the opioids, their side effects, and patient satisfaction with regards to pain treatment
in a Danish day surgery conducting orthopedic and abdominal surgery. The outcomes, including the use of opioids, self-reported
pain relief, and related side effects (nausea, fatigue, dizziness, and skin itchiness) were measured by a numeric rating scale and
patient satisfaction with regards to pain treatment.
Results: Out of the 199 included day surgery patients, 162 (81%) returned self-reported postoperative data. A total of 73% of the
patients had used opioids an average of 4 times (range 1 - 16). Median levels of nausea, dizziness, and skin itching were 0 (IQR 0 -
3) whereas the median level of fatigue was 3 (IQR 0 - 6). More than 90% of the patients were satisfied or very satisfied with their
postoperative pain treatment. No statistically significant differences were found between oxycodone and morphine in regard to
onset time, level, duration of pain treatment, and the experienced side effects.
Conclusions: Three-quarters of the patients used opioids after day surgery with a substantially varied number of doses. Few pa-
tients experienced substantial side effects, and the patients were generally satisfied with their pain treatment. No significant differ-
ence was found between oxycodone and morphine. The need for opioids after day surgery varies substantially and further investi-
gations on individuals and follow-up are needed.
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1. Background
During the last three decades, ambulatory surgery has
increasingly become popular due to the development of
surgical and anesthetic techniques (1, 2). However, one
of the challenges of ambulatory surgery is the need for
a sufficient and safe postoperative pain treatment proto-
col. Local anesthetics have been widely used, and in re-
cent years, ultrasound-guided techniques have improved
the quality of perioperative blockades (3, 4). Supplements,
pain treatment with paracetamol, and nonsteroidal anti-
inflammatory drugs (NSAID) constitute the base of post-
operative pain treatment (5, 6). In spite of these conven-
tional treatments, some patients still need supplemental
opioids, and oral pain treatment is most safely and eas-
ily administered out of a hospital. Oxycodone immediate-
release capsules (oxycodone IR) have become increasingly
popular as oral opioid therapy for postoperative pain (7).
Pharmacokinetic data indicate that oxycodone has a more
rapid uptake and longer duration than morphine (8, 9).
In some studies, the use of slow release oxycodone com-
pared to slow release morphine seem to show fewer side
effects, such as nausea and vomiting (10-12). Postoperative
nausea and vomiting are major problems in postoperative
care (13). A Cochrane review from 2009 suggested a single
dose of oxycodone IR for acute postoperative pain and con-
cluded that it is an effective analgesic for acute postopera-
tive pain (14).
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2. Objectives
Planned postoperative pain treatment is based on a
general expected need, but more knowledge is needed to
clarify which specific postoperative day surgery requires
opioid treatment and which opioid provides the best pain
management and the fewest side effects.
Therefore, the objectives of the current study were to
examine the need for opioids and the effects of morphine
and oxycodone IR for pain relief and the related side effects
at home after day surgery.
3. Methods
3.1. Design
The study was a prospective observational study using
a quasi-randomized approach conducted at a Danish day
surgery. The inclusion criteria were patients with surgical
procedures, which were expected to need oral treatment
with opioids within the first 3 days after surgery. The pa-
tients had to be over 17 years old. In addition, they had to
understand and speak Danish. The exclusion criteria were
patients with chronic pain, which was treated with opioids
(all types) and/or secondary analgesics as anticonvulsants
or antidepressants.
During the study period, pre- and per-operative pain
treatment was identical for all patients. Preoperatively, all
patients were treated with paracetamol 1 g orally. Some of
the orthopedic patients were not allowed NSAID due to the
risk of reduced bone-healing. This meant that no ortho-
pedic patient received NSAID on arrival, but they received
it later as intravenous administered ketorolac if accepted
by the surgeon. Patients in general surgery with a weight
> 50 kg received ibuprofen 600 mg orally before surgery.
The dosage was reduced to ibuprofen 400 mg in the case of
weight < 50 kg. By the age > 65 years, omeprazole 20 mg
orally was added, as long as NSAID was administered.
In the recovery room, pain management was based on
frequent assessments of the patients’ pain using the nu-
merical rating scale (NRS) 0 - 10. If NRS was below 4, no ex-
tra medication was offered. At NRS 4 - 6, NSAID was used if
not already given, otherwise oral opioid was administered.
At NRS 7 - 10, IV opioid and oral opioid was administered.
All patients had to have an NRS < 4 at the time of discharge
from the recovery room.
Postoperatively, all patients were recommended the
use of paracetamol 1 g × 4 and NSAID (a dose associated
to weight as described above) × 3 (unless it was decided
by the orthopedic surgeon) as baseline pain medication for
the first three days. Additionally, based on former patient
surveys of pain issues at home, specific operations were
identified as expected to require opioids. All patients re-
ceived necessary pieces of advice at arrival at the unit and
again before discharge on the use of pain scales and on
when and how to use the drugs.
3.2. Study Groups
The included patients were initially divided into three
groups in blocks of two weeks. In group A, patients re-
ceived pain treatment with opioids in accordance with the
current practice. This consisted of intravenous fentanyl,
intravenous morphine, and capsule oxycodone IR in the re-
covery room. Patients who were expected to need opioids
at home for the first 3 days were offered a package of oxy-
codone 5 mg IR capsules to take home. The number of cap-
sules was based on the current practice in accordance with
the surgical procedure, with some patients being offered
doses for 1.5 days and others for 3 days. With the recom-
mended daily dose administered at a frequency of 4 cap-
sules a day, this corresponds to either 6 or 12 capsules.
In group B, treatment in the recovery room was iden-
tical with group A, but oxycodone IR was replaced with
tablet morphine 10 mg for opioid use at home. The patients
were offered the same amount at home with respect to 1.5
or 3 days. Tablet morphine has to be administered with
a frequency of 6 per day to ensure a full daily dose. This
meant that the patients received either a total of 9 or 18
morphine tablets of 10 mg to take home. In group C, pa-
tient treatment in the recovery room consisted of intra-
venous fentanyl, intravenous morphine, and tablet mor-
phine. Treatment at home was identical to group B.
Using oral administration, it is impossible to achieve
the same equipotent doses of oxycodone and morphine,
as capsule oxycodone IR is available as 5 mg capsules and
tablet morphine as 10 mg tablets. The usual equipotent
dose is that a 5 mg oxycodone capsule taken orally is equal
to a 7.5 mg morphine tablet (15). As both oxycodone IR 5
mg and morphine 10 mg are commonly used in Danish
day surgery departments, the difference of 2.5 mg mor-
phine between equal dose morphine with oxycodone and
the available tablets was accepted.
The patients were placed in the groups in two-week
blocks. For the first two weeks, all the included patients
were placed in group A. For the following two weeks, the in-
cluded patients were placed in group B and then in group
C for two weeks after that. This continued until at least 50
patients were included in each group to ensure a substan-
tial participant population for analyses.
3.3. Data Registration
Patient’s data, surgery-related data, and the use of anal-
gesics were obtained from the anesthesia records. Data
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from the first 3 postoperative days were registered by the
patients using a registration form which covered each day.
The registration form was developed by the study group
and pilot tested on 6 patients. The form was returned by
mail in a pre-paid envelope. If the registration form was
not returned, a person not involved in patient treatment
made a reminder by telephone.
On the registration form for each day, the patients were
asked to register the use of the opioid with the addition of
an NRS-score before, 0.5 hour after and then 1 hour after
its administration. The patients were also asked to evalu-
ate the duration of the effect of the opioid, the use of other
pain-treating drugs, and their general satisfaction with the
treatment of their pain on a five-point Likert scale, and
their need to consult their own doctor or the emergency
department. The most common side effects of opioids pos-
sible for self-reporting (nausea, fatigue, dizziness, and itch-
ing) were also evaluated daily using the NRS, with 0 indicat-
ing no side effects and 10 indicating the worst possible.
3.4. Statistics
The base sample size was calculated based on the hy-
pothesis that there would be an NRS difference 0.5 hour af-
ter opioid intake of 2 (NRS 4 for oxycodone and 6 for mor-
phine) and a joint SD of 3.5. With an α of 0.05 and a β of
0.80, 48 patient had to be included in each group.
Categorical data were analyzed using the chi-square
test or the Fischer’s exact and the Kruskal Wallis test for
non-parametric continuous data. To adjust for the clus-
tered structure of the data, a mixed model with linear re-
gression and random effects was used to compare the ef-
fects and durability of the pain treatment, and a collapse
command using maximum the NRS values was used to
compare the side effects. A P value < 0.05 was considered
statistically significant.
4. Results
In the study period (April to September 2016), 288 pa-
tients were screened for possible participation. Here, 80
patients were excluded due to the project criteria, nine pa-
tients declined participation, and 199 patients agreed to
take part in the study. All patients were discharged on the
day of the surgery. A total of 162 patients (81%) returned the
postoperative registration forms, and 29 (18%) returned it
after a phone reminder. The 162 patients were from group
A: 55 patients, group B: 51 patients and group C: 56 patients.
Groups B and C were merged in the analyses between oxy-
codone and morphine because only two out of the 56 pa-
tients in group C received treatment with tablet morphine
in the recovery room, and therefore, treatment in the re-
covery room would have had only a minimal influence on
the postoperative use of the opioids and the side effects.
Table 1 presents the characteristics of the participants.
The majority of the patients were orthopedic. Prolonged
block refers to extending the blockade by adding dexam-
ethasone and or clonidine to the nerve block. There were
no significant differences between the groups, except plan
for posti-operative pain medication
The majority of the patients within each group were as-
sessed to need 1.5 day of opioid post-surgically. A total of 38
patients (13, 11, and 14) had received IV opioid in the recov-
ery room (data not shown). Table 2 shows that 73% of the
participants used opioids after day surgery, with a range
of between 50% (laparoscopic cholecystectomies) to 91%
(hand/arm surgery). The median number of doses taken
was 3.5 - 4 for all groups, but this covered a wide range be-
tween 1 and 16 doses. Orthopedic shoulder patients had the
widest range (1 - 16) and laparoscopic cholecystectomies
had the smallest one (2-8).
A total of 23 patients (15%) had contact with a doc-
tor from the emergency services (six from the oxycodone
group and 17 from the morphine group) with a total of
28 contacts. No statistically significant differences were
found in pain relief between oxycodone IR and tablet mor-
phine. The two groups had a reduction in the NRS of 1.9 and
1.6, respectively after 30 minutes (P = 0.30), and of 2.9 and
2.8 after one hour (P = 0.93). This corresponds to a measur-
able clinical effect (Table 3). The median levels of side ef-
fects of the opioids were zero, except for fatigue, which had
a median level of three. The 75% percentile was between
zero and six, but the full range for all four common side
effects was 0 - 10. No significant difference was found be-
tween morphine and oxycodone (Table 4).
More than 90% of the patients were either satisfied or
very satisfied with the pain treatment and no significant
differences were found between orthopedic or abdominal
surgery patients or between the oxycodone and morphine
groups (Table 5). Phone calls to remind the participants to
return the registration form revealed different postopera-
tive scenarios. An elderly lady had not had any pain, but
had taken the opioid every night because she then slept
very well. A few patients had serious pain issues after the
first three days of post-operation and had found it diffi-
cult to get help from the emergency services or their gen-
eral practitioner. Even though the medians for nausea and
dizziness were 0 and the IQR ranged from 0 to 2 - 3 (Ta-
ble 4), a few patients (both from the oxycodone and mor-
phine groups) had experienced serious side effects such as
fainting when standing up quickly after taking the opioid.
These patients would rather be in pain than risk a repeti-
tion of those particular side effects.
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Table 1. Patient Characteristicsa
Variables Total Oxycodone (N = 55) Morphine (N = 107) P Valueb
Women 108 (67) 34 (62) 74 (69) 0.35
Age median (IQR) 49 (36 - 57) 51 (36-59) 48 (35 - 57) 0.42
BMI 27 (23 - 30) 27 (23 - 30) 26 (23 - 29) 0.15
ASA classification
ASA 1 61 (38) 15 (27) 46 (43) 0.09
ASA 2 92 (57) 35 (63) 57 (53)
ASA 3 9 (6) 5 (9) 4 (4)
NRS arrival median (IQR) 2 (0 - 4) 2 (0 - 5) 1 (0 - 3) 0.39
Operation
Laparoscopic cholecystectomy 20 (12) 5 (9) 15 (14) 0.66
Other abdominal surgeries 11 (7) 4 (7) 7 (7)
Orthopedic 131 (81) 46 (84) 85 (79)
Shoulder 53 (40) 19 (41) 34 (40) 0.88
Foot 51 (39) 17 (37) 34 (40)
Knee 16 (12) 5 (11) 11 (13)
Hand/arm 11 (8) 5 (11) 6 (7)
Block before knife time 100 (81) 34 (77) 66 (83) 0.48
Type of nerve block
Femoral block 11 (9) 3 (7) 8 (10) 0.79
Interscalene block 53 (44) 19 (44) 34 (44)
Axillary block 7 (6) 4 (9) 3 (4)
Toe or ankle block 46 (38) 16 (37) 30 (38)
Femoral + obturator 4 (3) 1 (2) 3 (4)
Prolonged block (19) 8 (18) 15 (19) 0.89
Duration of operation median (IQR) 40 (27 - 60) 40 (27 - 65) 45 (28 - 59) 0.58
NRS max, recovery median (IQR) 0 (0 - 5) 0 (0 - 5) 1 (0 - 5) 0.21
Nausea, recovery 13 (8) 4 (7) 9 (8) 0.55
Vomiting, recovery 2 (1) 1 (2) 1 (1) 0.56
Plan for pain medication
1.5 day with opioid pnc 143 (88) 47 (86) 96 (90) 0.03
3 days with opioid pnc 6 (4) 5 (9) 1 (1)
Prescribed opioid (knee) 13 (8) 3 (5) 10 (9)
Abbreviations: ASA, American Society of Anesthesiologists Classification; BMI, body mass index; IQR, interquartile range; NRS, numeric rating scale.
a Values are expressed as No. (%) or No. (range).
b Chi-square test or Fischer’s exact test for categorical data and Mann-Whitney U-test for not normally distributed continuous data.
c pn: pro necessitate (as needed).
5. Discussion
Three-quarters of the patients used opioids after day
surgery with a substantially varied number of doses. Few
patients experienced substantial side effects, and the pa-
tients were generally satisfied with their pain treatment.
No significant difference was found between oxycodone
and morphine groups.
Although all studied participants were assumed to
need opioids as supplementary pain medication after day
surgery, a quarter did not use any opioid and the rest
(within all types of surgery) took a wide range of doses
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Table 2. The Number of the Patients Using Opioid and Doses







20 10 (50) 4 (2 - 8)
Other abdominal
surgeries
11 9 (82) 4 (1 - 11)
Orthopedic 131 100 (76) 4 (1 - 16)
Shoulder 53 43 (81) 4 (1 - 16)
Foot 51 35 (69) 4 (1 - 14)
Knee 16 12 (75) 3.5 (2 - 10)
Hand/arm 11 10 (91) 4 (1 - 10)
Total 162 119 (73) 4 (1 - 16)
regardless the type of operation. A recent review has ex-
amined post-discharge opioid consumption with the con-
clusion that surgical patients used substantially less opi-
oid than prescribed, The range of prescribed opioid com-
sumed varied from 11% to 90% (16).
As the patients were asked only to register levels of the
pain in relation to their opioid intake, the present study
does not provide a comprehensive overview of the levels
of the pain after day surgery. Therefore, the study cannot
prove whether the lack of the need to use opioids was due
to the absence of the pain, a mistrust of opioid, or an accep-
tance of certain levels of the pain. Studies have shown that
pain management is important for patients (17) and there
is a relationship between pain severity and patient satisfac-
tion (18). Furthermore, just being aware that you have an
option if the pain gets too strong may decrease use of opi-
oids.
Although more than 90% of the patients in this study
were satisfied or very satisfied with the pain treatment that
was offered, a small group remained to whom the treat-
ment was still not sufficient. A non-planned advantage of
the reminder phone calls was the collection of detailed in-
formation about the varied experiences of the patients re-
garding the pain and the side effects after day surgery. If
the pain prevailed, some of the patients did not have suf-
ficient options to manage their pain. Therefore, provid-
ing a high-quality postoperative pain treatment after day
surgery for all patients is comprised of clear (and usable)
options for what to do and whom to contact if standard
treatment is not sufficient.
Based on the pharmacokinetics (8, 9), the hypothesis
was that oxycodone would reduce NRS faster than mor-
phine. However, this study revealed no differences in the
clinical use of capsule oxycodone IR 5 mg and tablet mor-
phine 10 mg when comparing the effects and common
side-effects in a mixed population of day surgery patients.
This is in accordance with a study of pancreatic cancer
pain, which no significant differences were found in pain
and symptom intensity between oral morphine and oral
oxycodone (19). A study comparing IV morphine with IV
oxycodone after percutaneous kidney stone surgery could
not confirm their hypothesis that oxycodone would be su-
perior in the treatment of visceral pain (20).
The study was conducted with the clinically available
amount of the drugs. The national recommendations in
Denmark (15) prescribe that the equipotent oral doses are
5 mg oxycodone IR equal to 7.5 mg morphine. Several stud-
ies have evaluated the equipotent oral doses (21-23). The ra-
tio reported between oral oxycodone and oral morphine
varies from 1:1 to 1:2. With this variation in the estimated
potency, it can be argued that equipotent doses were given.
The onset time of oxycodone IR is supposed to be faster
than morphine when administered orally (8, 9), but this
was not found in this study when looking at the 30- and 60-
minute time points after intake. However, giving a larger
equipotent dose, in this case, morphine tablet will accel-
erate the onset time and could explain the same clinical
onset time. This could potentially induce a higher inci-
dence of side effects, but this was not found in the current
study. Oxycodone IR has become popular in postoperative
settings (7). Studies have shown that the duration of oxy-
codone IR is slightly longer than tablet morphine (8, 9, 15,
24), which could suggest why it has become the drug of
choice. However, a longer duration of oxycodone IR was
not shown in this study. The studies testing the controlled
released oxycodone and morphine also seem to show a dif-
ference in the side effects (10-12). This finding was not sup-
ported by the current study.
The strengths of the study include the high response
rate, the quasi-randomized approach, and the participa-
tion of a mixed population of day surgery patients, which
increases the generalizability of the results. However, the
mixed population with different surgeries and the use of
various medications and blocks during surgery are also
limitations to this study and the comparison between
groups should be considered with caution. The main
limitations are the only quasi-randomized and the non-
blinded study design, which may induce bias with respect
to the use of regional anesthesia blocks and other aspects
of patient handling. However, all surgery and anesthetic
procedures were carried out based on current practice and
were most likely not influenced by the study. A bias may
also be found in the non-systematic use of NSAIDs in or-
thopedic patients. Whether a patient was allowed to use
an NSAID or not, it would cause a potential difference be-
tween oxycodone and morphine. However, with the quasi-
randomized design, it is assessed that the using or not-
Ann Anesth Crit Care . 2018; 3(2):e81667. 5
Christiansen KW et al.
Table 3. Effect and Duration of Pain Medication
Total Oxycodone Morphine P Valuea
NRS before intake
Mean ± SD 5.9 ± 2.4 5.9 ± 2.1 5.9 ± 2.1
Regression coefficient (CI) 0 -0.2 (-1.0; 0.6) 0.62
NRS difference 0.5 hour
Mean ± SD -1.7 ± 1.6 -1.9 ± 1.8 -1.6 ± 1.5
Regression coefficient (CI) 0 0.3 (-0.3; 0.8) 0.30
NRS difference 1 hour
Mean ± SD -2.8 ± 2.0 -2.9 ± 2.0 -2.8 ± 2.0
Regression coefficient (CI) 0 0.03 (-0.6; 0.7) 0.93
Duration
Mean ± SD 4.5 ± 2.3 4.6 ± 1.9 4.5 ± 2.5
Regression coefficient (CI) 0 0.004 (-0.8; 0.8) 0.99
Abbreviations: CI, confidence interval; NRS, numeric rating scale; SD, standard deviation.
a A mixed model with linear regression and random effects.
Table 4. Side Effects
Variables Total Oxycodone Morphine P Valueb
N Median (IQR)a N Median (IQR)a N Median (IQR)a
Nausea 139 0 (0 - 2) 45 0 (0 - 2) 94 0 (0 - 3) 0.26
Fatigue 138 3 (0 - 6) 45 2 (0 - 5) 93 3 (0 - 6) 0.53
Dizziness 136 0 (0 - 3) 45 0 (0 - 3) 91 0 (0 - 3) 0.50
Skin itching 136 0 (0 - 0) 44 0 (0 - 0) 92 0 (0 - 0) 0.81
a Interquartile range.
b Mann-Whitney U-test based on collapse command using median NRS values.
Table 5. Satisfaction with Pain Treatmenta , b
Variable Total (N = 153) Orthopedic (N = 125) Abdominal Surgery (N = 28) P Value Oxycodone (N = 54) Morphine (N = 99) P Value
Very satisfied 84 (55) 71 (57) 14 (50) 0.73 32 (59) 53 (53) 0.76
Satisfied 56 (37) 45 (36) 11 (39) 18 (33) 38 (38)
Other 12 (8) 9 (7) 3 (11) 4 (7) 8 (8)
a Chi-square test based on collapse command using median values.
b Values are expressed as No. (%).
using NSAID individuals were equally divided between the
groups. Likewise, the non-equipotent doses of morphine
and oxycodone may induce bias in comparing. Although
a significant difference was found between the groups re-
garding the plan for opioid treatment at home, the vast
majority of subjects in all groups were assumed to need
opioid pn necessitate for 1.5 day. Therefore, this difference
most likely did not influence the results. Information is
missing on whether the patients adhered to the recom-
mendations of taking paracetamol and NSAID. However, it
is unlikely that there would be a difference between the
oxycodone and the morphine groups. Other side effects
such as constipation and sleepiness need more clarifica-
tion in further studies.
Although this is a prospective observational study with
a quasi-randomized approach, the study does not provide
solid evidence for differences between morphine and oxy-
codone. As neither the patients nor the researchers were
blinded, the risk of bias exists. Other limitations include a
lack of knowledge of reasons for either using or not using
opioid, having NRS scores only for patients taking opioids,
and the self-reported data, which could induce the risk of
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information biases. Reasons for using or not using opioids
would be interesting to pursue in future research. More
detailed knowledge about pain issues and pain levels after
day surgery for specific operations would be helpful in of-
fering optimal pain treatment for postoperative after day
surgery. However, the results from this study suggest that
there is no model that fits all, so more precise individual as-
sessment and follow-up are needed. A randomized double-
blinded controlled study still needs to be carried in order
to recommend the use either oxycodone or morphine.
5.1. Conclusions
Three-quarters of the patients used opioids after day
surgery with a substantially varied number of doses.
Few patients experienced substantial side effects, and the
patients were generally satisfied with their pain treat-
ment. No significant difference was found between oxy-
codone and morphine. The need for opioids after day
surgery varies substantially and individual assessments
and follow-up are needed.
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